Interleukin 1 Receptor 1 and Interleukin 1&bgr; Regulate Megakaryocyte Maturation, Platelet Activation, and Transcript Profile During Inflammation in Mice and Humans
暂无分享,去创建一个
E. Benjamin | J. Freedman | E. Mick | L. Beaulieu | M. Koupenova | K. Tanriverdi | M. Larson | C. Genco | E. Weinberg | Elaine Lin | C. Kramer | K. Tanrıverdi | Carolyn D. Kramer
[1] D. McManus,et al. Relationship Among Circulating Inflammatory Proteins, Platelet Gene Expression, and Cardiovascular Risk , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[2] D. Hanahan,et al. Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis , 2013, Oncogene.
[3] D. Vara,et al. The novel NOX inhibitor 2‐acetylphenothiazine impairs collagen‐dependent thrombus formation in a GPVI‐dependent manner , 2013, British journal of pharmacology.
[4] P. Libby,et al. Effects of Interleukin-1&bgr; Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen: A Phase IIb Randomized, Placebo-Controlled Trial , 2012, Circulation.
[5] Keiko Watanabe,et al. Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study. , 2012, Journal of periodontology.
[6] J. Freedman,et al. Platelets and platelet-like particles mediate intercellular RNA transfer. , 2012, Blood.
[7] Xi-Ping Feng,et al. Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on Secretion of IL1B, IL6, and IL8 by Gingival Epithelial Cells , 2012, Inflammation.
[8] G. Owens,et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. , 2012, The Journal of clinical investigation.
[9] Andrew J. Oler,et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. , 2011, Blood.
[10] P. Libby,et al. Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). , 2011, American heart journal.
[11] A. Leviton,et al. Persistence after birth of systemic inflammation associated with umbilical cord inflammation. , 2011, Journal of reproductive immunology.
[12] J. Freedman,et al. Regulatory effects of TLR2 on megakaryocytic cell function. , 2011, Blood.
[13] A. Mirza,et al. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. , 2011, Atherosclerosis.
[14] F. C. Gibson,et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. , 2011, Atherosclerosis.
[15] Andrew D. Johnson,et al. Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study , 2010, Circulation.
[16] E. Lien,et al. Inflammation and Fibrosis during Chlamydia pneumoniae Infection Is Regulated by IL-1 and the NLRP3/ASC Inflammasome , 2010, The Journal of Immunology.
[17] X. Liu,et al. Pathogen-Mediated Inflammatory Atherosclerosis Is Mediated in Part via Toll-Like Receptor 2-Induced Inflammatory Responses , 2010, Journal of Innate Immunity.
[18] N. Andersson,et al. Mice Chronically Fed High-Fat Diet Have Increased Mortality and Disturbed Immune Response in Sepsis , 2009, PloS one.
[19] D. R. Faber,et al. Role of adipose tissue in haemostasis, coagulation and fibrinolysis , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[20] David H Perlman,et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and α-granule release , 2009, Thrombosis and Haemostasis.
[21] A. Manning,et al. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells. , 2009, Molecular immunology.
[22] J. Freedman,et al. Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase , 2009, Circulation research.
[23] P. Vikman,et al. Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats. Laboratory investigation. , 2007, Journal of neurosurgery.
[24] K. Swoboda,et al. Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.
[25] J. Hawiger,et al. Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* , 2005, Journal of Biological Chemistry.
[26] K. Yudoh,et al. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal , 2005, Annals of the rheumatic diseases.
[27] J. Magovern,et al. Molecular dynamics of the compensatory response to myocardial infarct. , 2005, Journal of molecular and cellular cardiology.
[28] R. Levine,et al. Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model: Pharmacotherapeutic Implications , 2004, Circulation.
[29] Chi-kong Li,et al. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells. , 2004, The Journal of laboratory and clinical medicine.
[30] M. Seishima,et al. Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[31] F. C. Gibson,et al. Prevention of Porphyromonas gingivalis-Induced Oral Bone Loss following Immunization with Gingipain R1 , 2001, Infection and Immunity.
[32] D. Dixon,et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.
[33] I. Haznedaroglu,et al. Cytokines, Endothelium, and Adhesive Molecules in Pathologic Thrombopoiesis , 2001, Clinical and applied thrombosis/hemostasis.
[34] Chi-kong Li,et al. Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. , 2000, British journal of haematology.
[35] F. Neumann,et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. , 2000, Atherosclerosis.
[36] K. Werdan,et al. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. , 1998, Blood.
[37] C. Holt,et al. Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease , 1996 .
[38] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[39] C. Holt,et al. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[40] Y. Fu,et al. Cytokine production by primary bone marrow megakaryocytes. , 1994, Blood.
[41] C. Dinarello,et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. , 1993, Blood.
[42] S. Ohguni,et al. [Effect of subcutaneous administration of interleukin-1 beta on blood platelet count and serum GM-CSF in patients with myelodysplastic syndrome and aplastic anemia]. , 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[43] T. Uchida,et al. Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6. , 1990, Blood.
[44] E. Unanue,et al. Activated platelets express IL-1 activity. , 1989, Journal of immunology.
[45] D. Williams,et al. Alterations in megakaryocyte and platelet compartments following in vivo IL-1 beta administration to normal mice. , 1989, Journal of immunology.
[46] Y. Hirai,et al. Interleukin-1 potentiates granulopoiesis and thrombopoiesis by producing hematopoietic factors in vivo. , 1989, Life sciences.